ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EHC vs MRK // GROSS PROFIT MARGIN

Encompass Health Corporation (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: EHC 3 — MRK 10
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EHC VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EHC MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 74.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 13.80% 20.70% -6.90 MRK /roic <GO>
EV/EBITDA & P/E Valuation 15.8x 15.3x +0.50 MRK /valuation <GO>
Free Cash Flow Yield 2.92% 3.42% -0.50 MRK /fcf-yield <GO>
Operating Margin 11.60% 34.30% -22.70 MRK /operating-margins <GO>
Net Profit Margin 9.50% 28.10% -18.60 MRK /net-margins <GO>
Revenue Growth (YoY) 10.50% 1.30% +9.20 EHC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.55% 2.26% -1.71 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.47 5.19 -1.72 MRK /balance-sheet <GO>
Piotroski F-Score Quality 9/9 7/9 +2.00 EHC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 65.5 56.3 +9.20 EHC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 0.92 -0.02 MRK /macro-sensitivity <GO>
Forward P/E Multiple 21.3x 18.4x +2.90 MRK /forward-pe <GO>
Enterprise Scale & Market Cap $13.41B $368.89B -$355.48B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EHC REV MRK REV EHC GROSS % MRK GROSS % EHC FCF MRK FCF
FY 2025 $5.94B $65.01B — 74.8% — $12.36B
FY 2024 $5.37B $64.17B — 76.3% — $18.10B
FY 2023 $4.80B $60.12B — — — $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EHC // BETA 0.90
MRK // BETA 0.92